Epistatic effects of IGHG and FCGRIIB genes on the development of Alzheimer’s disease in African Americans
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Epistatic effects of IGHG and FCGRIIB genes on the development of Alzheimer’s disease in African Americans ; volume:77 ; number:1 ; day:4 ; month:11 ; year:2024 ; pages:1-7 ; date:12.2025
Immunogenetics ; 77, Heft 1 (4.11.2024), 1-7, 12.2025
- Urheber
-
Pandey, Janardan P.
Nietert, Paul J.
Namboodiri, Aryan M.
Bennett, David A.
Barnes, Lisa L.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00251-024-01358-4
- URN
-
urn:nbn:de:101:1-2501222102206.934689552941
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pandey, Janardan P.
- Nietert, Paul J.
- Namboodiri, Aryan M.
- Bennett, David A.
- Barnes, Lisa L.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Plaque complement activation and cognitive loss in Alzheimer's disease
Single-nucleus RNA velocity reveals critical synaptic and cell-cycle dysregulations in neuropathologically confirmed Alzheimer’s disease
Genome-wide epistasis analysis for Alzheimer’s disease and implications for genetic risk prediction
Protein farnesylation is upregulated in Alzheimer’s human brains and neuron-specific suppression of farnesyltransferase mitigates pathogenic processes in Alzheimer’s model mice
Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer’s disease subjects: an exploratory study
TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer’s disease
Mitigation of synaptic and memory impairments via F-actin stabilization in Alzheimer’s disease
Effects of brain microRNAs in cognitive trajectory and Alzheimer’s disease
Pathologic and clinical correlates of region-specific brain GFAP in Alzheimer’s disease
Unique transcriptional signatures correlate with behavioral and psychological symptom domains in Alzheimer’s disease
Characterization of mitochondrial DNA quantity and quality in the human aged and Alzheimer’s disease brain
BMI1 is associated with CS8F amyloid-β and rates of cognitive decline in Alzheimer’s disease
Plaque complement activation and cognitive loss in Alzheimer's disease
Single-nucleus RNA velocity reveals critical synaptic and cell-cycle dysregulations in neuropathologically confirmed Alzheimer’s disease
Genome-wide epistasis analysis for Alzheimer’s disease and implications for genetic risk prediction
Protein farnesylation is upregulated in Alzheimer’s human brains and neuron-specific suppression of farnesyltransferase mitigates pathogenic processes in Alzheimer’s model mice
Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer’s disease subjects: an exploratory study
TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer’s disease
Mitigation of synaptic and memory impairments via F-actin stabilization in Alzheimer’s disease
Effects of brain microRNAs in cognitive trajectory and Alzheimer’s disease
Pathologic and clinical correlates of region-specific brain GFAP in Alzheimer’s disease
Unique transcriptional signatures correlate with behavioral and psychological symptom domains in Alzheimer’s disease
Characterization of mitochondrial DNA quantity and quality in the human aged and Alzheimer’s disease brain
BMI1 is associated with CS8F amyloid-β and rates of cognitive decline in Alzheimer’s disease
Plaque complement activation and cognitive loss in Alzheimer's disease
Single-nucleus RNA velocity reveals critical synaptic and cell-cycle dysregulations in neuropathologically confirmed Alzheimer’s disease
Genome-wide epistasis analysis for Alzheimer’s disease and implications for genetic risk prediction
Protein farnesylation is upregulated in Alzheimer’s human brains and neuron-specific suppression of farnesyltransferase mitigates pathogenic processes in Alzheimer’s model mice
Specific serum antibody binding to phosphorylated and non-phosphorylated tau in non-cognitively impaired, mildly cognitively impaired, and Alzheimer’s disease subjects: an exploratory study
TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer’s disease
Mitigation of synaptic and memory impairments via F-actin stabilization in Alzheimer’s disease
Effects of brain microRNAs in cognitive trajectory and Alzheimer’s disease
Pathologic and clinical correlates of region-specific brain GFAP in Alzheimer’s disease
Unique transcriptional signatures correlate with behavioral and psychological symptom domains in Alzheimer’s disease
Characterization of mitochondrial DNA quantity and quality in the human aged and Alzheimer’s disease brain